Brief: Femasys Inc. Announces Enrollment Completion For Stage 2 Study Of Fembloc For Permanent Birth Control
06/10/2022 13:50
Oct 6 (Reuters) - Femasys Inc FEMY.O :
* FEMASYS INC. ANNOUNCES ENROLLMENT COMPLETION FOR STAGE 2
STUDY
OF FEMBLOC FOR PERMANENT BIRTH CONTROL
Source text for Eikon: ID:nGNX71X8kK
Further company coverage: FEMY.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Femasys
See all newsBrief: Femasys - Files For Resale Of Up To 28,124,997 Shares Of Common Stock - SEC Filing
Brief: Femasys Announces FDA Approval Of Modular Pma Submission Approach For Fembloc
Femasys Inc reports results for the quarter ended June 30 - Earnings Summary
Femasys Inc expected to post a loss of $1.30 a share - Earnings Preview
Femasys Inc expected to post a loss of $1.30 a share - Earnings Preview